In fact, before its identification as an m6A reader, IGF2BP2 had already suggested to be associated with tumor progression through preserving the stemness phenotype in glioblastoma and hepatocellular carcinoma [40–42]. Here, IGF2BP2 is linked to hepatocellular carcinoma.